IVX vs REG

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IVX

INVION FPO [IVX]

38LOW

REG

REG HEALTH FPO [REG]

38LOW

Score Breakdown

IVX REG
Technical
54
61
Catalyst
53
50
Sentiment
50
50
Fundamental
17
89
Momentum
44
50
Risk Gate
45
47

Key Metrics

IVX Metric REG
$7.4MMarket Cap$2.0B
78KAvg Volume (20d)601K
N/AShort Interest+1.1%
$0.20052-Week High$9.400
$0.07552-Week Low$5.800
+0.0%Daily Change+4.3%
$0.076Entry Price$6.510
-111.5%ROEN/A
N/AProfit Margin+3.0%

Active Signals

IVX Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.2 quarters)
●Pre-revenue with limited cash
●Piotroski F-Score weak (2/9, low-confidence approx)

REG Signals

●Above-average volume (1.7x) on a green day — buyers stepping up
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.6x)
●Moderate revenue growth (+18%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare IVX and REG in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IVX Full Analysis → REG Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).